Expression of Plakophilins (PKP1, PKP2, and PKP3) in Gastric Cancers
2011

Plakophilins in Gastric Cancer

Sample size: 54 publication Evidence: moderate

Author Information

Author(s): Demirag Guzin G, Sullu Yurdanur, Gurgenyatagi Dilek, Okumus Nilgun O, Yucel Idris

Primary Institution: Ondokuz Mayis University, Faculty of Medicine

Hypothesis

The study explores the relationship between plakophilins (PKP1, PKP2, PKP3) and gastric cancer.

Conclusion

Decreased PKP2 and PKP3 may serve as early prognostic markers in gastric cancer.

Supporting Evidence

  • PKP1 expression was unchanged in gastric cancer compared to normal tissues.
  • PKP2 and PKP3 were significantly decreased in gastric cancer.
  • Low PKP3 levels correlated with poor prognosis.
  • Mean disease-free survival was 38 months and overall survival was 42 months.

Takeaway

This study looked at proteins called plakophilins in stomach cancer and found that lower levels of two of these proteins might mean the cancer is worse.

Methodology

Immunohistochemistry was used to compare PKP expression in 34 gastric adenocarcinomas and 20 normal gastric tissues.

Limitations

The study had a relatively small sample size and focused only on specific plakophilins.

Participant Demographics

Mean age was 60.3 years, with a female to male ratio of 8/26.

Statistical Information

P-Value

0.0000001 for PKP2, 0.0001 for PKP3

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1746-1596-6-1

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication